AU2003229255A1 - Method of diagnosis and treatment for affective disorders - Google Patents
Method of diagnosis and treatment for affective disordersInfo
- Publication number
- AU2003229255A1 AU2003229255A1 AU2003229255A AU2003229255A AU2003229255A1 AU 2003229255 A1 AU2003229255 A1 AU 2003229255A1 AU 2003229255 A AU2003229255 A AU 2003229255A AU 2003229255 A AU2003229255 A AU 2003229255A AU 2003229255 A1 AU2003229255 A1 AU 2003229255A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- treatment
- affective disorders
- affective
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002385194A CA2385194A1 (en) | 2002-05-07 | 2002-05-07 | Method of diagnosis and treatment for affective disorders |
CA2,385,194 | 2002-05-07 | ||
PCT/CN2003/000330 WO2003095671A1 (en) | 2002-05-07 | 2003-05-07 | Method of diagnosis and treatment for affective disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003229255A1 true AU2003229255A1 (en) | 2003-11-11 |
Family
ID=29410089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003229255A Abandoned AU2003229255A1 (en) | 2002-05-07 | 2003-05-07 | Method of diagnosis and treatment for affective disorders |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003229255A1 (en) |
CA (1) | CA2385194A1 (en) |
WO (1) | WO2003095671A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100415020C (en) | 2005-10-31 | 2008-08-27 | 上海华为技术有限公司 | Code resource distribution method of high speed physical downward sharing channel |
-
2002
- 2002-05-07 CA CA002385194A patent/CA2385194A1/en not_active Abandoned
-
2003
- 2003-05-07 AU AU2003229255A patent/AU2003229255A1/en not_active Abandoned
- 2003-05-07 WO PCT/CN2003/000330 patent/WO2003095671A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2385194A1 (en) | 2003-11-07 |
WO2003095671A8 (en) | 2004-09-23 |
WO2003095671A1 (en) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003239474A1 (en) | Device and method for the treatment of cardiac disorders | |
WO2002086502A8 (en) | Methods for the diagnosis and treatment of bone disorders | |
AU2003286567A1 (en) | Methods for the treatment of skin disorders | |
AU2003297954A1 (en) | Method and apparatus for therapeutic treatment of back pain | |
AU2003224788A1 (en) | Method for treatment of tissue | |
AU2003246102A1 (en) | Method of examining allergic disease and drug for treating the same | |
AU2003301347A1 (en) | Methods for monitoring treatment of disease | |
AU2003258305A1 (en) | Combination therapy for treatment of fibrotic disorders | |
WO2004030615A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004016225A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1571968A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004045516A9 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
IL165950A0 (en) | Compositions and method for the diagnosis and treatment of tumor | |
EP1572091A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004060270A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003286741A1 (en) | Methods and compositions for diagnosis and therapy of parkin-associated disorders | |
IL162201A0 (en) | New methods for diagnosis and treatment of tumours | |
WO2003057160A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003287909A1 (en) | Electro-therapeutic device and method of electro-therapeutic treatment | |
AU2003291536A1 (en) | Method for the diagnosis and treatment of vascular disease | |
AU2003270536A1 (en) | Method of treating skin disorders | |
AU2003904328A0 (en) | Diagnosis and treatment of neurodegenerative disorders | |
AUPS194902A0 (en) | Compositions and methods for diagnosis and treatment of cardiovascular disorders | |
AU2003244132A1 (en) | Method of examining allergic disaese and drug for treating the same | |
EP1539100A4 (en) | Composition and methods for the treatment of skin disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 18, NO 2, PAGE(S) 568 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME PHARMACOGENETICS LIMITED , APPLICATION NO. 2003229255 , UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003 -11377- |